California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$84.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SCPH Sc Pharmaceuticals Inc.	$92.1M	$9,000 0.0% of portfolio	2,057	Q2 2024 Reduced 29.14%
STTK Shattuck Labs, Inc.	$58.1M	$9,000 0.0% of portfolio	2,834	Q2 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$149M	$9,000 0.0% of portfolio	10,705	Q2 2024 Reduced 19.76%
VTYX Ventyx Biosciences, Inc.	$111M	$9,000 0.0% of portfolio	4,404	Q2 2024 Reduced 6.42%
PEPG Pep Gen Inc.	$108M	$9,000 0.0% of portfolio	1,126	Q2 2024 Added 11.49%
CADL Candel Therapeutics, Inc.	$123M	$9,000 0.0% of portfolio	1,436	Q2 2024 New
CHRS Coherus Bio Sciences, Inc.	$59.8M	$8,000 0.0% of portfolio	7,976	Q2 2024 Reduced 24.43%
XFOR X4 Pharmaceuticals, Inc	$23.3M	$8,000 0.0% of portfolio	12,176	Q2 2024 Reduced 3.31%
PGEN Precigen, Inc.	$183M	$8,000 0.0% of portfolio	9,172	Q2 2024 Reduced 30.7%
FENC Fennec Pharmaceuticals Inc.	$115M	$8,000 0.0% of portfolio	1,698	Q2 2024 Reduced 6.96%
GBIO Generation Bio Co.	$99.1M	$8,000 0.0% of portfolio	3,585	Q2 2024 Reduced 21.26%
BLUE Bluebird Bio, Inc.	$27.8M	$7,000 0.0% of portfolio	13,885	Q2 2024 Reduced 27.89%
PBYI Puma Biotechnology, Inc.	$136M	$7,000 0.0% of portfolio	2,999	Q2 2024 New
VERU Veru Inc.	$50.5M	$7,000 0.0% of portfolio	9,571	Q2 2024 New
CRDF Cardiff Oncology, Inc.	$120M	$7,000 0.0% of portfolio	2,839	Q2 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$106M	$7,000 0.0% of portfolio	3,039	Q2 2024 New
TNYA Tenaya Therapeutics, Inc.	$83.6M	$7,000 0.0% of portfolio	3,997	Q2 2024 Reduced 14.43%
RGLS Regulus Therapeutics Inc.	$22M	$7,000 0.0% of portfolio	4,576	Q2 2024 New
KOD Kodiak Sciences Inc.	$276M	$6,000 0.0% of portfolio	2,364	Q2 2024 Reduced 27.51%
GLSI Greenwich Life Sciences, Inc.	$175M	$6,000 0.0% of portfolio	433	Q2 2024 New
QSI Quantum Si Inc	$93.2M	$6,000 0.0% of portfolio	7,257	Q2 2024 Reduced 29.06%
OVID Ovid Therapeutics Inc.	$81M	$5,000 0.0% of portfolio	4,267	Q2 2024 Reduced 28.82%
IPSC Century Therapeutics, Inc.	$74.2M	$5,000 0.0% of portfolio	3,324	Q2 2024 Added 41.15%
INMB Inmune Bio, Inc.	$97.6M	$5,000 0.0% of portfolio	1,078	Q3 2024 Added 21.81%
GALT Galectin Therapeutics Inc	$158M	$4,000 0.0% of portfolio	1,476	Q2 2024 New
RAPT Rapt Therapeutics, Inc.	$38M	$4,000 0.0% of portfolio	2,174	Q2 2024 Reduced 90.57%
ALXO Alx Oncology Holdings Inc	$54.2M	$4,000 0.0% of portfolio	2,393	Q3 2024 Reduced 90.52%
HOWL Werewolf Therapeutics, Inc.	$57M	$4,000 0.0% of portfolio	2,209	Q2 2024 New
HLVX Hille Vax, Inc.	$64.5M	$4,000 0.0% of portfolio	2,284	Q3 2024 Reduced 88.8%
ATNM Actinium Pharmaceuticals, Inc.	$41.6M	$4,000 0.0% of portfolio	2,178	Q2 2024 Reduced 21.82%
AVTE Aerovate Therapeutics, Inc.	$62.6M	$2,000 0.0% of portfolio	977	Q2 2024 Reduced 13.08%
ELEV Elevation Oncology, Inc.	$13.7M	$2,000 0.0% of portfolio	3,780	Q2 2024 New
PRLD Prelude Therapeutics Inc	$37.5M	$1,000 0.0% of portfolio	955	Q2 2024 Reduced 36.16%
LYRA Lyra Therapeutics, Inc.	$5.73M	$0 0.0% of portfolio	3,507	Q2 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	37,402	Q3 2024 Added 9.1%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.